Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection-Reference-Cited by-同舟云学术

Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection

Published:2015-07-14 Issue:13 Volume:75 Page:1484-1491
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Gandaglia Giorgio¹,Schiffmann Jonas²,Schlomm Thorsten²³,Fossati Nicola¹,Moschini Marco¹,Suardi Nazareno¹,Chun Felix K. H.³,Montorsi Francesco¹,Graefen Markus²,Briganti Alberto¹

Affiliation:

1. Unit of Urology/Division of Oncology, URI; IRCCS Ospedale San Raffaele; Milan Italy

2. Martini-Clinic Prostate Cancer Center; University Medical Center Hamburg-Eppendorf; Hamburg Germany

3. Department of Urology; University Center Hamburg-Eppendorf; Hamburg Germany

Publisher

Wiley

Subject

Urology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pros.23040/fullpdf

Reference33 articles.

1. European Association of U. EAU guidelines on prostate cancer. Part 1: Screening , diagnosis, and local treatment with curative intent-update 2013;Heidenreich;Eur Urol,2014